Aflunov

Aflunov is a vaccine designed to protect against the H5N1 influenza strain. It is administered intramuscularly and is manufactured by Seqirus S.R.L. in the EU. This vaccine is intended for use in preventing influenza caused by the H5N1 virus.

Aflunov is used to provide immunity against the H5N1 influenza strain, commonly known as avian flu. It is typically administered to individuals who are at risk of exposure to this particular strain of the virus. The vaccine works by stimulating the body's immune system to produce antibodies that can fight off the H5N1 virus. People often wonder, 'What is Aflunov used for?' and the primary use is for the prevention of influenza caused by the H5N1 strain.

After receiving the Aflunov vaccine, some individuals may experience common effects such as soreness at the injection site, mild fever, or fatigue. These effects are usually temporary and resolve within a few days. It is important to note that not everyone will experience these effects, and they are generally mild and manageable.

Before receiving the Aflunov vaccine, it is important to inform your healthcare provider about any allergies or medical conditions you have. Individuals with a history of severe allergic reactions to vaccines or any of the components in Aflunov should exercise caution. Always follow the advice of your healthcare provider regarding the administration and handling of this vaccine.

Aflunov may interact with other medications or vaccines. It is advisable to discuss any current medications or recent vaccinations with your healthcare provider before receiving Aflunov. Additionally, certain immune-suppressing drugs or conditions may affect the effectiveness of the vaccine. Always consult with a healthcare professional for personalized advice.